Call us:

Home | Specialties | Endocrinologist | Dr Nele F Lenders

Dr Nele F Lenders

Endocrinologist

BSc MBBS FRACP PhD

Dr Nele F Lenders

Dr Nele Lenders is an endocrinologist with a commitment to providing excellent and evidence-based care to patients. She has a special interest in pituitary disease, sports endocrinology, metabolic disease, polycystic ovarian syndrome (PCOS), functional hypothalamic amenorrhea (FHA), menopause and bone health. She also accepts referrals for a range of general endocrine conditions, including adrenal disease, diabetes and thyroid disorders.

Nele has a PhD in Pituitary Disease, completed through the Garvan Institute of Medical Research and University of New South Wales. She has a passion for research and its translation to clinical practice. She has numerous publications in the field of endocrinology and regularly presents at national and international conferences. Nele is a Staff Specialist Endocrinologist at St Vincent’s Hospital (Sydney) and is a Lecturer with UNSW School of Medicine.

In her spare time, Nele enjoys cooking, spending time with family, her dog, playing sport and running marathons.

Publications

  • Lenders NF, Thompson TJ, Chui J, Low J, Inder WJ, Earls PE, McCormack AI. Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2. Pituitary. 2024.
  • Lenders NF, Earls PE, Wilkinson AC, Costin M, Hofer M, Shein TT, Harvey RJ, Krishnan G, Picallo M, Pal A, Wass J, McCormack AI. Predictors of pituitary tumour behaviour – an analysis from long term follow up in two tertiary centres. Eur J Endocrinol. (2023).
  • Lenders NF, McCormack AI. Refractory PIT-1 plurihormonal and TSH adenomas. Pituitary (2023).
  • Lenders NF, Earls PE, Inder WJ, McCormack AI. The evolution in pituitary tumour classification: a clinical perspective. Endocrine Oncology (2023).
  • De Sousa S, Lenders NF, Lamb LS, Inder WJ, McCormack AI. Pituitary tumours: molecular and genetic aspects. Journal of Endocrinology (2023).
  • Lenders NF, Chui J, Low J, Inder WJ, Earls PE & McCormack AI. Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours. Pituitary (2022) 25 997-1003.
  • Lenders NF, Wilkinson AC, Wong SJ, Shein TT, Harvey RJ, Inder WJ, Earls PE & McCormack AI. Transcription factor immunohistochemistry in the diagnosis of pituitary tumours. Eur J Endocrinol (2021).
  • Lenders NF, Inder WJ & McCormack AI. Towards precision medicine for clinically non-functioning pituitary tumours. Clin Endocrinol (2021).
  • Lenders NF, McCormack AI, Ho KKY. MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly? Eur J Endocrinol. (2020) ;182(5):R67-R82.
  • Lenders NF, Greenfield JR. Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass. Endocrinol Diabetes Metab Case Rep. (2019).
  • Lenders N, McCormack A. Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma). Pituitary. (2018);21(2):217-29.
  • Ratnasingam J, Lenders N, Ong B, Boros S, Russell AW, Inder WJ, et al. Predictors for secondary therapy after surgical resection of nonfunctioning pituitary adenomas. Clin Endocrinol (2017) ;87(6):717-24.
  • Lenders N, Ikeuchi S, Russell AW, Ho KK, Prins JB, Inder WJ. Longitudinal evaluation of the natural history of conservatively managed nonfunctioning pituitary adenomas. Clin Endocrinol (2015).

Abstracts and presentations

  • Invited Oral Presentation at International Pituitary Pathology Club 2023: Transcription factor immunohistochemistry in the diagnosis of pituitary tumours.
  • Invited Oral Presentation at International Pituitary Pathology Club 2023: Development of a cost-effective algorithm for pituitary tumour diagnosis.
  • Invited Oral Presentation at Korean Endocrine Society Meeting 2023: Towards precision medicine for pituitary tumours.
  • Endocrine Society of Australia Annual Scientific Meeting 2024 - Bryan Hudson Finalist for Best Clinical Research Oral Presentation: Predictors of Pituitary Tumour Outcomes.
  • Endocrine Society of Australia Annual Scientific Meeting 2023 - Bryan Hudson Finalist for Best Clinical Research Oral Presentation: Co-Expressing Pituitary Tumours Express Stem Cell Marker SOX2.
  • Endocrine Society of Australia / Australia & New Zealand Pituitary Alliance Annual Meeting 2023 – Winner Best Clinical Research Oral Presentation: Predictors of Pituitary Tumour Outcomes.
  • Invited Oral Presentation at Endocrine Society of Australia Annual Scientific Meeting 2022: Evolution of classification of pituitary tumours.
  • Invited Oral Presentation at Endocrine Society of Australia Seminar 2021: Case of adult growth hormone deficiency.
  • Poster Presentation at US ENDO 2021: Transcription factor immunohistochemistry in the diagnosis of pituitary tumours.
  • Poster Presentation at US ENDO Pituitary Congress 2019: Predictors of Pituitary Tumour recurrence and aggressiveness.
  • Invited Oral Presentation at Neurosurgery Society of Australia Annual Meeting 2018: Pre-operative SSA in Acromegaly.
  • Poster Presentation at Endocrine Society of Australia Annual Scientific Meeting 2018: Masquerade or Mystery.
  • Poster Presentation at Endocrine Society of Australia Annual Scientific Meeting 2017: Rapidly Enlarging Prolactinoma.
  • Poster Presentation at Endocrine Society of Australia Annual Scientific Meeting 2016: Cutaneous calcinosis with refractory osteoporosis and hypocalcaemia.
  • Oral Presentation at Endocrine Society of Australia Annual Scientific Meeting 2014: The natural history of non-functioning pituitary adenomas: a longitudinal volumetric evaluation.

For all appointments at her Moore Park rooms, please contact reception on (02) 8323 6500.

facebook-profile-pic

The Stadium Clinic acknowledges the Gadigal people of the Eora Nation as the traditional custodians of the land on which we are fortunate to work and live, and we recognise their continuing connection to land, water, and community.